HCID 23138622, compound → HCID 23138658, compound

HRID 1171684Notes

Reaction equation

HRID 1171684 reaction equation
[ClH:1].[CH:2]1([C:5](=[O:32])[CH:6]([N:14]2[CH2:19][CH2:18][CH:17]([SH:20])/[C:16](=[CH:21]/[C:22]3[N:23]=[N:24][N:25]([CH2:27][C:28]([O:30]C)=[O:29])[N:26]=3)/[CH2:15]2)[C:7]2[CH:12]=[CH:11][CH:10]=[CH:9][C:8]=2[F:13])[CH2:4][CH2:3]1>C(#N)C>[ClH:1].[C:28]([CH2:27][N:25]1[N:24]=[N:23][C:22](/[CH:21]=[C:16]2\[CH2:15][N:14]([CH:6]([C:7]3[CH:12]=[CH:11][CH:10]=[CH:9][C:8]=3[F:13])[C:5]([CH:2]3[CH2:3][CH2:4]3)=[O:32])[CH2:19][CH2:18][CH:17]\2[SH:20])=[N:26]1)([OH:30])=[O:29]

Participants

3

Procedure

(E)-1-[2-cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl]-3-{[2-(methoxycarbonylmethyl)-2H-tetrazol-5-yl]methylidene}-4-sulfanylpiperidine hydrochloride (135 mg) was subjected to the procedure similar to that described in Example 134. After purification by preparative HPLC (YMC-Pack ODS-A; YMC, eluent: acetonitrile/0.024 N hydrochloric acid, 25/75, v/v), the title compound (91.6 mg, yield: 70%) was obtained as a colourless amorphous solid.

Workup

  1. customAfter purification by preparative HPLC (YMC-Pack ODS-A

Sources & evidence

ORD record
ord-66e23f4fa2d146878280bb7a8da266e8
Source dataset
uspto-grants-2010_11
Patent number
US07829580B2

Reaction notes

Loading…